News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
233 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (3098)
February (3516)
March (3513)
April (3269)
May (4089)
June (3205)
July (2932)
August (3176)
September (2859)
October (3385)
November (3129)
December (2245)
Day
4 (233)
5 (213)
6 (181)
7 (106)
10 (145)
11 (135)
12 (157)
13 (141)
14 (109)
17 (140)
18 (165)
19 (162)
20 (153)
21 (108)
24 (157)
25 (156)
26 (145)
27 (150)
28 (103)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
GE Healthcare Launches Modular Biopharmaceutical Factory, KUBio
September 4, 2012
·
1 min read
Business
Vertex Pharmaceuticals (MA) Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
September 4, 2012
·
1 min read
FDA
HemCon Medical Technologies, Inc. GuardIVa®Antimicrobial Hemostatic IV Dressing Obtains Additional FDA Clearance and HCPCS Reimbursement Codes
September 4, 2012
·
1 min read
Drug Development
Kythera Biopharmaceuticals Completes Enrollment in Pivotal U.S. and Canadian Phase III Clinical Trials to Evaluate ATX-101 for Reduction of Submental Fat
September 4, 2012
·
1 min read
Genetown
ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences
September 4, 2012
·
1 min read
Policy
IMPAX Laboratories, Inc. Announces Settlement of Litigation Relating to RENVELA® and RENAGEL®
September 4, 2012
·
1 min read
Drug Development
Alnylam Pharmaceuticals Presents Complete Results from Phase IIb Trial with ALN-RSV01, an Inhaled RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
September 4, 2012
·
1 min read
Drug Development
Zalicus Inc. Initiates the First of Two Phase 2a Studies with Z160, a First-in-Class, Oral, State-Dependent, Selective N-type Calcium Channel Blocker, for the Treatment of Chronic Neuropathic Pain
September 4, 2012
·
1 min read
BioCapital
Rexahn Pharmaceuticals, Inc. Provides Update on 2012 Strategic Goals
September 4, 2012
·
1 min read
Drug Development
InterMune, Inc. Reports New Analyses From the RECAP Study of Esbriet® (Pirfenidone) at ERS
September 4, 2012
·
9 min read
Previous
14 of 24
Next
